Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The role of dehydroepiandrosterone (DHEA) in schizophrenia (CROSBI ID 227857)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Vuksan-Ćusa, Bjanka ; Šagud, Marina ; Radoš, Iva The role of dehydroepiandrosterone (DHEA) in schizophrenia // Psychiatria Danubina, 28 (2016), 1; 30-33

Podaci o odgovornosti

Vuksan-Ćusa, Bjanka ; Šagud, Marina ; Radoš, Iva

engleski

The role of dehydroepiandrosterone (DHEA) in schizophrenia

Neurosteroid dehydropiandrosterone (DHEA) and its sulphate (DHEAS) are reported to have modulatory effects on neuronal excitabillity and synaptic plasticity. DHEA and DHEAS are synthesized in central and peripheral nervous system from cholesterol or steroidal precursors imported from peripheral sources. There is accumulating evidence that alterations in DHEA(S) levels may be involved in the pathophysiology of schizophrenia. The possible effects of DHEA(S) as augmentation therapy in schizophrenia, related to psychological and somatic aspects of this disease, are discussed.

schizophrenia – dehydroepiandrosterone – DHEA – DHEAS - augmentation therapy

PMID: 26938818 PubMed.

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

28 (1)

2016.

30-33

objavljeno

0353-5053

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost